Justin A. Boyd

FDA investigator · also recorded as A. Boyd, Hale Justin A. Boyd

Appears on 61 documents from 2010 to 2026, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

61
Documents on file
9.3
Observations per 483
2010
First seen
2026
Most recent

What they cite most

From 524 observations

Activity by year

2010: 2, 2011: 2, 2012: 2, 2013: 1, 2015: 2, 2016: 3, 2017: 4, 2018: 4, 2019: 6, 2021: 1, 2022: 8, 2023: 8, 2024: 7, 2025: 9, 2026: 2

Where

India 21 · China 6 · Wisconsin 5 · France 3 · Germany 3 · Singapore 3

Is Justin A. Boyd coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

61 documents, newest first
FirmOpen
Warning letter Excel VisionJan 22, 2026 · Annonay, France
483 Excel VisionJan 22, 2026 · Annonay, France
483 Pharmathen International S.A. Industrial Park, Sapes Rodopi PrefectureNov 21, 2025 · Rodopi, Greece
483 Baxter Onocology GmbHSep 26, 2025 · Halle (Westf.), Germany
483 Fareva AmboiseSep 16, 2025 · Poce Sur Cisse, France
483 Sun Pharmaceutical Industries LtdJun 13, 2025 · Halol, India
483 Sun Pharmaceutical Industries Ltd.Jun 2, 2025 · Halol, India

About this profile

What does Justin A. Boyd inspect?

Justin A. Boyd appears on 61 documents on file covering 52 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Justin A. Boyd is dated Jan 22, 2026.